Seres Therapeutics Stock Discussion

$Seres Therapeutics (MCRB.US)$ Reuters
1 min ago
Seres Therapeutics Stockholders Approve Sale of Vowst™ to Nestlé Health Science; Sale Expected to Close on September 30

$Seres Therapeutics (MCRB.US)$
Seres Therapeutics Stockholders Approve Sale of VOWST™ to Nestlé Health Science; Sale Expected to Close on September 30

$Seres Therapeutics (MCRB.US)$
Seres Therapeutics Reports SER-155 Phase 1b Placebo-Controlled Cohort 2 Study Safety and Clinical Results in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)
Seres Therapeutics (Nasdaq: MCRB) reports positive results from the Phase 1b placebo-controlled study of SER-155 in patients undergoing allogeneic hematopoietic stem cell transplant (allo-HSCT). The study showed:
Significant reduction in bacterial bloodstream infections (BSIs) a...

$Seres Therapeutics (MCRB.US)$ Reuters· 2 mins ago
Seres Therapeutics Inc - to Receive $175M Cash Infusion
to Fully Retire Debt
Seres: Potential for Additional Future Commercial Milestone Payments of up to $275M From Vowst Sales Targets
plus additional 75 million in 2025

$Seres Therapeutics (MCRB.US)$ 👀

Follow Our Official Telegram Channel tynkrlab
$Dow Jones Industrial Average (.DJI.US)$ rose by 0.59% to a new record high, closing at 41,211.12. In contrast, the $S&P 500 Index (.SPX.US)$ fell by 1.39%, and the $Nasdaq Composite Index (.IXIC.US)$ dropped by 2.76%. Tech stocks faced significant pressure, contributing to the mixed market performance.
Key Drivers
1. Strong Performers: $UnitedHealth (UNH.US)$, $Johnson & Johnson (JNJ.US)$, and $Cisco (CSCO.US)$ l...